President Trump’s efforts to address substance use disorders continued under the SUPPORT for Patients and Communities Reauthorization Act of 2025. The U.S. Department of Health and Human Services (HHS)…
Read MoreNarcan
White House Seeks Increased Access to Overdose-Reversal Drug
Officials will talk with manufacturers to reduce the cost of naloxone. A spokesperson for the White House Office of National Drug Control Policy (ONDCP) recently said that President…
Read More